Gemigliptin, Dapagliflozin, Empagliflozin DDI Study

NCT03565458 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Gemigliptin
DRUG: Dapagliflozin
DRUG: Empagliflozin

Sponsor

LG Chem